Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bartsch

Showing results (81-90 of 228) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|April 17, 2013
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysisFlora Zagouri, Theodoros N Sergentanis, Rupert Bartsch, et al.
Future Oncology (London, England)|November 25, 2022
PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABCMichael Patrick Lux, Eva Diana Runkel, Esther Glastetter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2024
Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patientsGeorg Jeryczynski, Christoph Krall, Sabina Pasalic, et al.
Clinical Breast Cancer|November 30, 2021
The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBCChris Twelves, Rupert Bartsch, Noa Efrat Ben-Baruch, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2021
Tissue distribution of epirubicin after severe extravasation in humansJakob Nedomansky, Werner Haslik, Ursula Pluschnig, et al.
Breast Care (Basel, Switzerland)|November 5, 2010
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast CancerSimon P Gampenrieder, Rupert Bartsch, Peter Matzneller, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis StudyHanna L Obermeier, Julia Riedl, Cihan Ay, et al.
Plos One|August 22, 2014
Indocyanine green video angiography predicts outcome of extravasation injuriesWerner Haslik, Ursula Pluschnig, Günther G Steger, et al.
Pancreas|June 19, 2013
Molecularly targeted therapies in metastatic pancreatic cancer: a systematic reviewFlora Zagouri, Theodoros N Sergentanis, Dimosthenis Chrysikos, et al.
ESMO Open|September 1, 2018
CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussionMatthias Preusser, Leticia De Mattos-Arruda, Marc Thill, et al.
Pageof 23

Showing results (81-90 of 228) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|April 17, 2013
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysisFlora Zagouri, Theodoros N Sergentanis, Rupert Bartsch, et al.
Future Oncology (London, England)|November 25, 2022
PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABCMichael Patrick Lux, Eva Diana Runkel, Esther Glastetter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2024
Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patientsGeorg Jeryczynski, Christoph Krall, Sabina Pasalic, et al.
Clinical Breast Cancer|November 30, 2021
The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBCChris Twelves, Rupert Bartsch, Noa Efrat Ben-Baruch, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2021
Tissue distribution of epirubicin after severe extravasation in humansJakob Nedomansky, Werner Haslik, Ursula Pluschnig, et al.
Breast Care (Basel, Switzerland)|November 5, 2010
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast CancerSimon P Gampenrieder, Rupert Bartsch, Peter Matzneller, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis StudyHanna L Obermeier, Julia Riedl, Cihan Ay, et al.
Plos One|August 22, 2014
Indocyanine green video angiography predicts outcome of extravasation injuriesWerner Haslik, Ursula Pluschnig, Günther G Steger, et al.
Pancreas|June 19, 2013
Molecularly targeted therapies in metastatic pancreatic cancer: a systematic reviewFlora Zagouri, Theodoros N Sergentanis, Dimosthenis Chrysikos, et al.
ESMO Open|September 1, 2018
CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussionMatthias Preusser, Leticia De Mattos-Arruda, Marc Thill, et al.
Pageof 23